Yahoo! Finance: Top Stories

Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition

Feb 12, 2025 - 13:23
 0
Biogen expects lower 2025 profit as multiple sclerosis drugs face fierce competition
Read More

Tags:

Previous Article

WEC Energy: Buy Now After The Latest Dividend Hike

Next Article

Burger King parent beats quarterly estimates on strong demand

Related Posts